News

All
Animation
Event
Funding
Publication
Thesis

CEPR’s team 4 obtained a 4-year grant from the ANR (AAPG2024) to evaluate the mechanisms that control Innate T cells…

4-year ANR funding obtained (PROJECT COORDINATION: M. Si-Tahar): Development of Succinate-based analogues and formulations against SARS-CoV-2 and influenza viruses-induced respiratory infections – (SuccesS)

The emergence of pandemic respiratory viruses is a major concern. Those viruses include coronaviruses such as SARS-CoV-2 and influenza A…

Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein »

Publication

Antoine Guillon, Deborah Brea-Diakite, Adeline Cezard, Alan Wacquiez, Thomas Baranek, Jérôme Bourgeais, Frédéric Picou, Virginie Vasseur, Léa Meyer, Christophe Chevalier,…

Human proteinase 3 resistance to inhibition extends to alpha-2 macroglobulin.

Publication

N’Guessan K, Grzywa R, Seren S, Gabant G, Juliano MA, Moniatte M, van Dorsselaer A, Bieth JG, Kellenberger C, Gauthier…

Interleukin- 7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response.

Publication

Hassane M, Jouan Y, Creusat F, Soulard D, Boisseau C, Gonzalez L, Patin EC, Heuzé-Vourc’h N, Sirard JC, Faveeuw C,…

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!

Publication

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Sécher T, Mayor A, Heuzé-Vourc’h N.…

CEPR’s team 4 obtained a 4-year grant from the ANR (AAPG2023) to assess the role and functions of MAIT cells during influenza infection (coordinator: Y. Jouan).

Funding

End of Content.

News

CEPR’s team 4 obtained a 4-year grant from the ANR (AAPG2024) to evaluate the mechanisms that control Innate T cells…

4-year ANR funding obtained (PROJECT COORDINATION: M. Si-Tahar): Development of Succinate-based analogues and formulations against SARS-CoV-2 and influenza viruses-induced respiratory…

Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein »

Human proteinase 3 resistance to inhibition extends to alpha-2 macroglobulin.

Interleukin- 7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response.

Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!

CEPR’s team 4 obtained a 4-year grant from the ANR (AAPG2023) to assess the role and functions of MAIT cells…